Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Route of Administration for Doxycycline in Various Infections

Clinical Scenarios Where Route of Administration Matters

  • Patients with impaired gastrointestinal absorption or ileus may require IV doxycycline, according to the American Academy of Family Physicians 1
  • Initial treatment of life-threatening infections such as inhalational anthrax should be IV, then switch to oral when clinically appropriate, as recommended by the American Academy of Family Physicians 2
  • Severe septicemic or pneumonic plague may require IV doxycycline, according to the Centers for Disease Control and Prevention (CDC) 3
  • Severe Lyme disease with neurological manifestations may require IV doxycycline, although evidence suggests oral doxycycline may be adequate, as stated by the Infectious Diseases Society of America (IDSA) 4

Evidence from Specific Conditions

  • For cutaneous anthrax without systemic involvement, oral therapy is recommended by the American Academy of Family Physicians 2
  • For early Lyme disease with erythema migrans, oral doxycycline is recommended by the IDSA 5
  • For blood culture-negative endocarditis caused by certain pathogens like Brucella spp. and Bartonella spp., oral doxycycline (sometimes with other agents) is recommended by the European Society of Cardiology 6

Important Considerations When Choosing Route

  • The severity of infection and patient's clinical status should be considered when choosing the route of administration, as stated by the CDC 3